<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="24261">Glucocorticoids</z:chebi> are potent regulators of protein, fat, and carbohydrate metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>To determine if <z:chebi fb="1" ids="17650">cortisol</z:chebi> production occurs within the splanchnic bed in humans, 11 nondiabetic subjects were studied using the hepatic/leg catheterization method along with an infusion of [9,11,12,12-2H4] <z:chebi fb="1" ids="17650">cortisol</z:chebi> (D4-<z:chebi fb="1" ids="17650">cortisol</z:chebi>) as proposed by Andrews et al </plain></SENT>
<SENT sid="2" pm="."><plain>In the fasting state, there was net release (P &lt; 0.05) of <z:chebi fb="1" ids="17650">cortisol</z:chebi> from the splanchnic bed (6.1 +/- 2.6 microg/min) and net uptake (P &lt; 0.05) by the leg (1.7 +/- 0.7 microg/min) </plain></SENT>
<SENT sid="3" pm="."><plain>This, along with <z:chebi fb="1" ids="17650">cortisol</z:chebi> production by other tissues (e.g., the adrenals), resulted in a total-body <z:chebi fb="1" ids="17650">cortisol</z:chebi> appearance rate of 18.1 +/- 1.9 microg/min </plain></SENT>
<SENT sid="4" pm="."><plain>Fractional splanchnic D4-<z:chebi fb="1" ids="17650">cortisol</z:chebi> extraction averaged 12.9 +/- 1.3% (P &lt; 0.001), splanchnic <z:chebi fb="1" ids="17650">cortisol</z:chebi> uptake 14.8 +/- 2.0 microg/min (P &lt; 0.001), and splanchnic <z:chebi fb="1" ids="17650">cortisol</z:chebi> production 22.2 +/- 3.3 microg/min (P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>On the other hand, fractional leg D4-<z:chebi fb="1" ids="17650">cortisol</z:chebi> extraction averaged 5.6 +/- 1.8% (P &lt; 0.02), leg <z:chebi fb="1" ids="17650">cortisol</z:chebi> uptake 2.3 +/- 0.7 microg/min (P &lt; 0.01), and leg <z:chebi fb="1" ids="17650">cortisol</z:chebi> production 0.4 +/- 0.4 microg/min, which did not differ from zero </plain></SENT>
<SENT sid="6" pm="."><plain>Because D4-<z:chebi fb="1" ids="17650">cortisol</z:chebi> loses a <z:chebi fb="5" ids="29237">deuterium</z:chebi> during conversion to [9,12,12-2H3] <z:chebi fb="11" ids="16962">cortisone</z:chebi> (D3-<z:chebi fb="11" ids="16962">cortisone</z:chebi>), which in turn generates [9,12,12(2)H3] <z:chebi fb="1" ids="17650">cortisol</z:chebi> (D3-<z:chebi fb="1" ids="17650">cortisol</z:chebi>) via 11-beta <z:chebi fb="0" ids="35350">hydroxysteroid</z:chebi> dehydrogenase (11beta-HSD) type 1, D3-<z:chebi fb="1" ids="17650">cortisol</z:chebi> production can be used as an index of 11beta-HSD type 1 activity </plain></SENT>
<SENT sid="7" pm="."><plain>Net splanchnic D3-<z:chebi fb="1" ids="17650">cortisol</z:chebi> release (3.9 +/- 0.4 microg/min) and splanchnic D3-<z:chebi fb="1" ids="17650">cortisol</z:chebi> production (7.1 +/- 0.7 microg/min) occurred (P &lt; 0.01) in <z:hpo ids='HP_0000001'>all</z:hpo> subjects </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, there was minimal leg D3-<z:chebi fb="1" ids="17650">cortisol</z:chebi> production (0.04 +/- 0.01 microg/min), resulting in a strong correlation between splanchnic D3-<z:chebi fb="1" ids="17650">cortisol</z:chebi> production and total-body 3D-<z:chebi fb="1" ids="17650">cortisol</z:chebi> production in both the fasting state (r = 0.84; P &lt; 0.02) and during an infusion of insulin (r = 0.97; P &lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, splanchnic production of <z:chebi fb="1" ids="17650">cortisol</z:chebi> occurs in nondiabetic humans at rates approximating that which occurs in the remainder of the body </plain></SENT>
<SENT sid="10" pm="."><plain>These data support the possibility that alterations in splanchnic <z:chebi fb="1" ids="17650">cortisol</z:chebi> production contribute to visceral fat accumulation and the hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> of <z:hpo ids='HP_0001513'>obesity</z:hpo> or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>